Nuvisan is a full-service CRO and CDMO headquartered in France with state-of-the-art laboratories in Germany and France. The company provides integrated drug discovery and development services spanning omics and biomarkers, compound screening, pharmacology, chemistry, preclinical safety, bioanalysis, clinical services (Phase 1 and 2), and CMC services including drug substance and drug product manufacturing, pharmaceutical analytical services, and clinical trial supply management.
drug discovery and preclinical services, IMP manufacturing for Phase 1, pharmaceutical analytical services (small and large molecules), clinical trial supply services, bioanalysis and biomarkers
2 sites worldwide
No reviews available yet.
No documents available.